(Q39012547)

8 September 2017

title

Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment (English)

1 reference

8 September 2017

0 references

0 references

0 references

Timothy D McHugh

15

0 references

Norbert Heinrich

Norbert Heinrich

11

0 references

Patrick Phillips

Patrick Pj Phillips

7

0 references

Stephen H Gillespie

Stephen H Gillespie

16

0 references

Alimuddin Zumla

Alimuddin Zumla

14

0 references

Michael Hoelscher

18

Michael Hoelscher

1 reference

8 September 2017

3

Elmar Saathoff

1 reference

8 September 2017

13

Martin J Boeree

1 reference

8 September 2017

Sven O Friedrich

1

1 reference

8 September 2017

Andrea Rachow

2

1 reference

8 September 2017

Kasha Singh

4

1 reference

8 September 2017

Chacha D Mangu

5

1 reference

8 September 2017

Rodney Dawson

6

1 reference

8 September 2017

Amour Venter

8

1 reference

8 September 2017

Anna Bateson

9

1 reference

8 September 2017

Catharina C Boehme

10

1 reference

8 September 2017

Robert D Hunt

12

1 reference

8 September 2017

Andreas H Diacon

17

1 reference

8 September 2017

Pan African Consortium for the Evaluation of Anti-tuberculosis Antibiotics (PanACEA)

19

1 reference

8 September 2017

publication date

1 July 2013

1 reference

The Lancet. Respiratory medicine

8 September 2017

published in

1 reference

8 September 2017

volume

1

1 reference

8 September 2017

issue

6

1 reference

8 September 2017

page(s)

462-470

1 reference

Scaling up interventions to achieve global tuberculosis control: progress and new developments

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970119-X

7 January 2021

Advancing the development of tuberculosis therapy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970119-X

7 January 2021

Innovative Trial Designs Are Practical Solutions for Improving the Treatment of Tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970119-X

7 January 2021

Predicting the outcome of therapy for pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970119-X

7 January 2021

Sensitivity of fluorochrome microscopy for detection of Mycobacterium tuberculosis versus nontuberculous mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970119-X

7 January 2021

Randomized dose-ranging study of the 14-day early bactericidal activity of bedaquiline (TMC207) in patients with sputum microscopy smear-positive pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970119-X

7 January 2021

Direct comparison of Xpert MTB/RIF assay with liquid and solid mycobacterial culture for quantification of early bactericidal activity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970119-X

7 January 2021

Delamanid for multidrug-resistant pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970119-X

7 January 2021

Assessment of new sterilizing drugs for treating pulmonary tuberculosis by culture at 2 months

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970119-X

7 January 2021

Time to liquid culture positivity can substitute for colony counting on agar plates in early bactericidal activity studies of antituberculosis agents

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970119-X

7 January 2021

Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970119-X

7 January 2021

Immunological biomarkers of tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970119-X

7 January 2021

Polymerase chain reaction for assessing treatment response in patients with pulmonary tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970119-X

7 January 2021

Measurement of sputum Mycobacterium tuberculosis messenger RNA as a surrogate for response to chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970119-X

7 January 2021

Molecular bacterial load assay, a culture-free biomarker for rapid and accurate quantification of sputum Mycobacterium tuberculosis bacillary load during treatment

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970119-X

7 January 2021

Comparison of quantitative techniques including Xpert MTB/RIF to evaluate mycobacterial burden

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970119-X

7 January 2021

Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970119-X

7 January 2021

Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970119-X

7 January 2021

A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970119-X

7 January 2021

Rapid molecular detection of tuberculosis and rifampin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970119-X

7 January 2021

Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay--a clinical validation study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970119-X

7 January 2021

Evaluation of the analytical performance of the Xpert MTB/RIF assay.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970119-X

7 January 2021

Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970119-X

7 January 2021

Sputum Mycobacterium tuberculosis mRNA as a marker of bacteriologic clearance in response to antituberculosis therapy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970119-X

7 January 2021

Strand displacement amplification and the polymerase chain reaction for monitoring response to treatment in patients with pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970119-X

7 January 2021

Early tuberculosis treatment monitoring by Xpert(R) MTB/RIF.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-2600%2813%2970119-X

7 January 2021

10.1016/S2213-2600(13)70119-X

Identifiers

DOI

1 reference

8 September 2017

1 reference